invokana
Generic: canagliflozin
Labeler: janssen pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
invokana
Generic Name
canagliflozin
Labeler
janssen pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
canagliflozin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50458-141
Product ID
50458-141_30ca5702-272c-7528-e063-6294a90abbc1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA204042
Listing Expiration
2026-12-31
Marketing Start
2013-03-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50458141
Hyphenated Format
50458-141
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
invokana (source: ndc)
Generic Name
canagliflozin (source: ndc)
Application Number
NDA204042 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)
- 10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30)
- 500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50)
- 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)
Packages (5)
50458-141-01
5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)
50458-141-10
10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
50458-141-30
30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30)
50458-141-50
500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50)
50458-141-90
90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "30ca5702-272c-7528-e063-6294a90abbc1", "openfda": {"upc": ["0350458141900", "0350458140903"], "unii": ["0SAC974Z85"], "rxcui": ["1373463", "1373469", "1373471", "1373473"], "spl_set_id": ["b9057d3b-b104-4f09-8a61-c61ef9d4a3f3"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)", "package_ndc": "50458-141-01", "marketing_start_date": "20130329"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "50458-141-10", "marketing_start_date": "20130329"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30)", "package_ndc": "50458-141-30", "marketing_start_date": "20130329"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50)", "package_ndc": "50458-141-50", "marketing_start_date": "20130329"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)", "package_ndc": "50458-141-90", "marketing_start_date": "20130329"}], "brand_name": "INVOKANA", "product_id": "50458-141_30ca5702-272c-7528-e063-6294a90abbc1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50458-141", "generic_name": "canagliflozin", "labeler_name": "Janssen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "300 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20261231"}